NO20011847L - Gener for å vurdere kardiovaskul¶r status og sammensetninger for anvendelse derav - Google Patents

Gener for å vurdere kardiovaskul¶r status og sammensetninger for anvendelse derav

Info

Publication number
NO20011847L
NO20011847L NO20011847A NO20011847A NO20011847L NO 20011847 L NO20011847 L NO 20011847L NO 20011847 A NO20011847 A NO 20011847A NO 20011847 A NO20011847 A NO 20011847A NO 20011847 L NO20011847 L NO 20011847L
Authority
NO
Norway
Prior art keywords
genes
compositions
cardiovascular status
assessing cardiovascular
assessing
Prior art date
Application number
NO20011847A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011847D0 (no
Inventor
Leif Torbjoern Nordberg
Maria Kristina Andersson
Per Harry Rutger Lindstroem
Lena Jonsson
Original Assignee
Pyrosequencing Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pyrosequencing Ab filed Critical Pyrosequencing Ab
Publication of NO20011847D0 publication Critical patent/NO20011847D0/no
Publication of NO20011847L publication Critical patent/NO20011847L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • C12N9/0079—Steroid 11 beta monooxygenase (P-450 protein)(1.14.15.4)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • C12N9/6486—Renin (3.4.23.15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/23—Aspartic endopeptidases (3.4.23)
    • C12Y304/23015—Renin (3.4.23.15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20011847A 1998-10-14 2001-04-10 Gener for å vurdere kardiovaskul¶r status og sammensetninger for anvendelse derav NO20011847L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10430298P 1998-10-14 1998-10-14
US10428698P 1998-10-14 1998-10-14
PCT/IB1999/001678 WO2000022166A2 (fr) 1998-10-14 1999-10-13 Genes d'evaluation d'etat cardio-vasculaire et compositions d'utilisations associees

Publications (2)

Publication Number Publication Date
NO20011847D0 NO20011847D0 (no) 2001-04-10
NO20011847L true NO20011847L (no) 2001-06-14

Family

ID=26801367

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011847A NO20011847L (no) 1998-10-14 2001-04-10 Gener for å vurdere kardiovaskul¶r status og sammensetninger for anvendelse derav

Country Status (7)

Country Link
EP (1) EP1121462A2 (fr)
JP (1) JP2002527079A (fr)
AU (1) AU6116399A (fr)
CA (1) CA2347247A1 (fr)
IL (1) IL142548A0 (fr)
NO (1) NO20011847L (fr)
WO (1) WO2000022166A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938390A1 (de) * 1999-08-05 2001-03-08 Max Delbrueck Centrum Neue Sequenzvarianten des menschlichen ßl-Adrenozeptorgens und ihre Verwendung
WO2002000933A2 (fr) * 2000-06-23 2002-01-03 Interleukin Genetics, Inc. Essais de recherche systematique de modulateurs de la reaction inflammatoire ou immunitaire
US20030113726A1 (en) * 2000-12-04 2003-06-19 Zenta Tsuchihashi Human single nucleotide polymorphisms
DE10065666B4 (de) * 2000-12-29 2008-10-02 Wiesner, Rudolf, Prof. Dr. DNA-Chip zur kausalen Diagnose von Bluthochdruck
WO2002063045A1 (fr) * 2001-02-02 2002-08-15 Genaissance Pharmaceuticals, Inc. Isogenes cibles de medicament: polymorphismes dans le gene du recepteur 2 de l'angiotensine
EP1394267A1 (fr) * 2002-08-19 2004-03-03 Bayer HealthCare AG Polymorphismes à nucléotide unique permettant de pronostiquer les maladies cardio-vasculaires, les effets secondaires et l'efficacité des medicaments
JP4502570B2 (ja) * 2002-09-24 2010-07-14 株式会社東洋紡ジーンアナリシス 遺伝子多型解析を用いたＩｇＡ腎症診断およびＩｇＡ腎症診断用キット
EP1802775B1 (fr) 2004-09-14 2010-05-26 The Regents of the University of Colorado Procédé de traitement faisant intervenir du bucindolol fondé sur le ciblage génétique
EP1851329B1 (fr) * 2005-02-02 2012-06-20 The Royal College of Surgeons in Ireland Pharmacogenomics des agents abaissant de la tension artérielle
WO2006102177A2 (fr) * 2005-03-22 2006-09-28 Novartis Ag Bio-marqueurs pour l'evaluation de l'efficacite de l'aliskirene en tant qu'agent hypertensif
WO2007008604A2 (fr) * 2005-07-08 2007-01-18 Bristol-Myers Squibb Company Polymorphismes de nucleotides simples associes a l'oedeme dose-dependant, et leurs procedes d'utilisation
WO2010001358A2 (fr) 2008-07-03 2010-01-07 Mor Research Applications Ltd Polymorphismes diagnostiques d'une maladie cardiaque

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6549186A (en) * 1985-10-24 1987-05-19 Biotechnology Research Partners Limited Blood tests diagnostic for hypertension
WO1988008457A1 (fr) * 1987-04-30 1988-11-03 Biotechnology Research Partners, Ltd. Tests sanguins relatifs a l'hypertension utiles a titre de marqueurs genetiques
US5580722A (en) * 1989-07-18 1996-12-03 Oncogene Science, Inc. Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease
US6197505B1 (en) * 1997-04-04 2001-03-06 Pyrosequencing Ab Methods for assessing cardiovascular status and compositions for use thereof
AU2510799A (en) * 1997-12-30 1999-08-09 Max-Delbruck-Centrum Fur Molekulare Medizin Novel sequence variants of the human beta2-adrenergic receptor gene and use thereof

Also Published As

Publication number Publication date
WO2000022166A2 (fr) 2000-04-20
JP2002527079A (ja) 2002-08-27
CA2347247A1 (fr) 2000-04-20
NO20011847D0 (no) 2001-04-10
IL142548A0 (en) 2002-03-10
EP1121462A2 (fr) 2001-08-08
AU6116399A (en) 2000-05-01
WO2000022166A3 (fr) 2000-09-14

Similar Documents

Publication Publication Date Title
NO20013157D0 (no) Preparater for kardiovaskul¶re indikasjoner
DE69912108D1 (de) Polyesterharzzusammensetzungen zum kalandrieren
NO20011847L (no) Gener for å vurdere kardiovaskul¶r status og sammensetninger for anvendelse derav
DE69908242D1 (de) Reformer
DE69825295D1 (de) Küchen-mixer für umkehrbare drehrichtung
DE69830160D1 (de) Bleichmittelzusammensetzungen
DE69802031D1 (de) Reversibele thermochromische Zusammensetzungen
DE69903157D1 (de) Persönliche waschmittelzusammensetzungen
BR9708853A (pt) Composição em barra
DE69736382D1 (de) Chemilumineszente zusammensetungen und ihre verwendung zum nachweis von wasserstoffperoxid
BR9708736A (pt) Composição em barra
BR9709701A (pt) Composição em barra
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
NO995560D0 (no) Reologi omforming og omformingsmidler
DE69737652D1 (de) Selbstverdickende Bleichmittelzusammensetzungen
NO20004284D0 (no) Antikorrosjonspigment og anvendelse derav
BR9708090A (pt) Composição em barra
DE59808032D1 (de) Rührwerksmühle
DE59909568D1 (de) Rührwerksmühle
NO20031177D0 (no) Fremgangsmåter og sammensetninger for glykosidaseanalyser
GB2342158B (en) Electrooptic probe
FR2779445B1 (fr) Kit d'encapsidation
GB2337606B (en) Test rig
DE69730717D1 (de) Bleichmittelzusammensetzungen für Wäsche
FR2787038B1 (fr) Petrin batteur melangeur

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application